Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Operating Leases: 2021-2025

Historic Operating Leases for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $90.3 million.

  • Roivant Sciences' Operating Leases rose 108.02% to $89.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.8 million, marking a year-over-year increase of 108.02%. This contributed to the annual value of $90.3 million for FY2025, which is 100.64% up from last year.
  • Latest data reveals that Roivant Sciences reported Operating Leases of $90.3 million as of FY2025, which was down 0.17% from $90.5 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Operating Leases registered a high of $90.5 million during FY2024, and its lowest value of $45.0 million during FY2024.
  • In the last 3 years, Roivant Sciences' Operating Leases had a median value of $53.5 million in 2023 and averaged $65.3 million.
  • As far as peak fluctuations go, Roivant Sciences' Operating Leases declined by 15.81% in 2024, and later spiked by 100.64% in 2025.
  • Over the past 5 years, Roivant Sciences' Operating Leases (Yearly) stood at $62.4 million in 2021, then reached $62.1 million in 2021, then increased by 0.13% to $62.5 million in 2022, then decreased by 11.54% to $54.9 million in 2022, then decreased by 14.39% to $53.5 million in 2023, then decreased by 14.32% to $47.1 million in 2023, then decreased by 15.81% to $45.0 million in 2024, then spiked by 92.27% to $90.5 million in 2024, then soared by 100.64% to $90.3 million in 2025.